Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 2

    USFDA Requests Removal of All Ranitidine Products (Zantac) from the Market

    USFDA Requests Removal of All Ranitidine Products (Zantac) from the Market

    Medical Dialogues Bureau6 April 2020 3:45 AM GMT
    The U.S. Food and Drug Administration has announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine...
    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Medical Dialogues Bureau3 April 2020 8:47 AM GMT
    New Delhi: Genetic diagnostics firm MedGenome has said it has raised USD 55 million (over Rs 415 crore) in funding led by LeapFrog...
    Takeda appoints Koki Sato as new country head for India

    Takeda appoints Koki Sato as new country head for India

    Medical Dialogues Bureau3 April 2020 8:35 AM GMT
    New Delhi: Takeda India has announced the appointment of Koki Sato as the Country Head for the Company's India business. In his current capacity,...
    Aurobindo, Sandoz call off 900 million US dollar deal

    Aurobindo, Sandoz call off 900 million US dollar deal

    Medical Dialogues Bureau2 April 2020 9:57 AM GMT
    New Delhi: Aurobindo Pharma on Thursday said the USD 900 million deal to acquire Sandoz Inc''s US-based generic oral solids and dermatology...
    Medical devices to be regulated as drugs for quality control, price monitoring: Government

    Medical devices to be regulated as drugs for quality control, price monitoring: Government

    Medical Dialogues Bureau1 April 2020 6:14 AM GMT
    Delhi: All medical devices shall be regulated by the government as drugs for quality control and price monitoring from April 1, 2020, the Ministry of...
    Minister Asks Pharma Companies To Contribute In PM-CARE Fund Under CSR

    Minister Asks Pharma Companies To Contribute In PM-CARE Fund Under CSR

    Medical Dialogues Bureau1 April 2020 4:00 AM GMT
    Delhi: Through a recent release, D.V. Sadananda Gowda, Minister of Chemicals & Fertilizers requested all the pharmaceuticals companies to...
    Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; to Supply One Billion Vaccines

    Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; to Supply One Billion Vaccines

    Medical Dialogues Bureau31 March 2020 7:36 AM GMT
    New Brunswick: Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since...
    Sanofi delays Slump Sale and transfer of Ankleshwar plant

    Sanofi delays Slump Sale and transfer of Ankleshwar plant

    Medical Dialogues Bureau30 March 2020 10:00 AM GMT
    Gujrat: Sanofi has announced the change in date for the closing of a transaction relating to Slump Sale and transfer of its manufacturing facility of...
    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

    Medical Dialogues Bureau29 March 2020 7:49 AM GMT
    New Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
    Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus

    Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus

    Medical Dialogues Bureau28 March 2020 8:00 AM GMT
    Hertfordshire & Pittsburgh: Mylan N.V. and Pfizer Inc. today announced that due to the unprecedented circumstances surrounding the COVID-19...
    With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19

    With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19

    Medical Dialogues Bureau28 March 2020 6:39 AM GMT
    Abbott will be making ID NOW COVID-19 tests available next week to healthcare providers in urgent care settings in the U.S., where the majority of ID...
    Hydroxychloroquine now a Prescription Drug: Health Ministry gazette puts it in Schedule H1 of DCA

    Hydroxychloroquine now a Prescription Drug: Health Ministry gazette puts it in Schedule H1 of DCA

    Medical Dialogues Bureau27 March 2020 7:37 AM GMT
    New Delhi: Soon after banning the export of the Drug Hydroxychloroquine in light of the coronavirus, the government has now made the Drug into a...
    PrevNext

    Popular Stories

    FDA seizes unlicensed medical devices worth over Rs 1 crore from GT Hospital

    FDA seizes unlicensed medical devices worth over Rs 1 crore from GT Hospital

    Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

    Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

    Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

    Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    Pharmaceuticals safe in PET packaging: High-level committee

    Pharmaceuticals safe in PET packaging: High-level committee

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok